Sassari, Italy

Alessandro Falchi


 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations of Alessandro Falchi

Introduction

Alessandro Falchi is a notable inventor based in Sassari, Italy. He has made significant contributions to the field of chemistry, particularly in the synthesis of pharmaceutical compounds. With a total of three patents to his name, Falchi's work has had a meaningful impact on the development of important medications.

Latest Patents

Falchi's latest patents include a process for the preparation of Brinzolamide, which is a compound used in the treatment of glaucoma. This invention details a method for synthesizing Brinzolamide via intermediates, specifically 2,3-dihydro-4H-thieno[3,2-e]-1,2-thiazin-4-ones. Another significant patent involves a process for preparing intermediates useful in the synthesis of Imatinib, a medication used to treat certain types of cancer. This patent focuses on the synthesis of 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine and its analogues.

Career Highlights

Throughout his career, Falchi has worked with reputable companies such as Fabbrica Italiana Sintetici S.p.a. and PHF S.a. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects in the pharmaceutical industry.

Collaborations

Falchi has collaborated with notable colleagues, including Ennio Grendele and Riccardo Motterle. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Alessandro Falchi's contributions to the field of chemistry and pharmaceuticals are commendable. His innovative patents and collaborations highlight his dedication to advancing medical science. His work continues to influence the development of important therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…